-transparent.png){kind=logo}
A group of young patients having multiple sclerosis was treated with dietary supplements containing calcium, magnesium and vitamin D for a period of one to two years. The experimental design employed self-pairing: the response of each patient was compared with his/her own case history as control. The number of exacerbations observed during the program was less than one half the number expected from case histories. No side effects were apparent. The dietary regimen may offer a new means of controlling the exacerbation rate in MS, at least for younger patients. The results tend to support a theory of MS which states that calcium and magnesium are important in the development, structure and stability of myelin.
P Goldberg, and
M C Fleming, and
E H Picard
November 2016,
Multiple sclerosis and related disorders,
P Goldberg, and
M C Fleming, and
E H Picard
July 2012,
Therapeutic advances in neurological disorders,
P Goldberg, and
M C Fleming, and
E H Picard
May 2010,
Annals of neurology,
P Goldberg, and
M C Fleming, and
E H Picard
November 2008,
Multiple sclerosis (Houndmills, Basingstoke, England),
P Goldberg, and
M C Fleming, and
E H Picard
June 2022,
Nutricion hospitalaria,
P Goldberg, and
M C Fleming, and
E H Picard
October 2020,
Maturitas,
P Goldberg, and
M C Fleming, and
E H Picard
October 2021,
Cureus,
P Goldberg, and
M C Fleming, and
E H Picard
May 2004,
Meat science,
P Goldberg, and
M C Fleming, and
E H Picard
February 2015,
Journal of neuroimmunology,
P Goldberg, and
M C Fleming, and
E H Picard
January 2020,
Multiple sclerosis journal - experimental, translational and clinical,
